🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical research study is to learn if 5-aza-2 deoxycytidi...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2009-04
Trial ID
NCT00882102
Treatments Being Tested
This study investigates the efficacy, safety, and pharmacokinetics of sugam...
Status
Completed
Location
Multiple Locations
Start Date
2002-12-01
Trial ID
NCT03519854
Treatments Being Tested
This study will evaluate the immunogenicity, safety, and tolerability of VA...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0018)
Start Date
2017-10-17
Trial ID
NCT03239873
Treatments Being Tested
Assess the safety and immunogenicity of a 3-dose schedule (at 2, 4, 6 month...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-09-11
Trial ID
NCT02173704
Treatments Being Tested
This is a study to evaluate the immune response and safety of GSK Biologica...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-10-06
Trial ID
NCT00197015
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0159)
Start Date
2019-06-19
Trial ID
NCT03893448
Treatments Being Tested
Primary Objective: 1. To describe the vaccine seroprotection (antibody tit...
Status
Completed
Location
Investigational Site Number :4840001
Start Date
2018-10-17
Trial ID
NCT03630705
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of a...
Status
Completed
Location
Hansa Sanatorium GmbH
Start Date
2016-08-17
Trial ID
NCT02861586
Treatments Being Tested
This pilot study will test intra-lesional immunotherapy (MMR vaccine) injec...
Status
Recruiting
Location
Mansoura University Hospital
Start Date
2025-12-09
Trial ID
NCT07312604
Treatments Being Tested
This is a multicenter, non-randomized, open-label, phase II study evaluatin...
Status
Recruiting
Location
West Virginia University Cancer Institute
Start Date
2026-01-15
Trial ID
NCT07222579
Treatments Being Tested